The impact of weight loss on circulating cytokines in Beagle dogs

Veterinary Immunology and Immunopathology

Volumn 163, Issue 3-4, 2015, Pages 174-182

  Bastien, Berenice C ^a   Patil, Avinash ^a   Satyaraj, Ebenezer ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

IL 18; IL 7; Inflammation; MCP 1; Obesity

Indexed keywords

ADIPONECTIN; ALPHA TOCOPHEROL; ASCORBIC ACID; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLUCAGON; GLUCOSE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INSULIN; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; KERATINOCYTE CHEMOKINE; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BEAGLE; BLOOD SAMPLING; BODY FAT; BODY WEIGHT; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT MASS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIMIT OF DETECTION; MALE; NONHUMAN; OBESITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; WEIGHT REDUCTION; ANIMAL; DOG; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM; PHYSIOLOGY;

CANIS FAMILIARIS; RODENTIA;

ANIMALS; CYTOKINES; DOGS; FEMALE; GENE EXPRESSION REGULATION; INFLAMMATION; MALE; WEIGHT LOSS;

EID: 84922254919     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2014.12.003     Document Type: Article

References (34)

1. Azzini E., Polito A., Fumagalli A., Intorre F., Venneria E., Durazzo A., Zaccaria M., Ciarapica D., Foddai M.S., Mauro B., Raguzzini A., Palomba L., Maiani G. Mediterranean Diet Effect: an Italian picture. Nutr. J. 2011, 10:125.
2. Benzie I.F., Strain J.J. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal. Biochem. 1996, 239:70-76.
3. Burtis C.A., Ashwood E.R. Tietz Textbook of Clinical Chemistry 1999, Saunders, Philadelphia.
4. de Jager W., Bourcier K., Rijkers G.T., Prakken B.J., Seyfert-Margolis V. Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunol. 2009, 10:52.
5. de Luca C., Olefsky J.M. Inflammation and insulin resistance. FEBS Lett. 2008, 582:97-105.
6. DeClue A.E., Sharp C.R., Harmon M. Plasma inflammatory mediator concentrations at ICU admission in dogs with naturally developing sepsis. J. Vet. Intern. Med. 2012, 26:624-630.
7. Eirmann L.A., Fleeman L.M., Laflamme D.P., Michel K.E., Satyaraj E. Comparison of adipokine concentrations and markers of inflammation in obese versus lean dogs. J. Appl. Res. Vet. Med. 2009, 7:196-205.
8. Gayet C., Bailhache E., Dumon H., Martin L., Siliart B., Nguyen P. Insulin resistance and changes in plasma concentration of TNFalpha, IGF1, and NEFA in dogs during weight gain and obesity. J. Anim. Physiol. Anim. Nutr. (Berl.) 2004, 88:157-165.
9. German A.J. The growing problem of obesity in dogs and cats. J. Nutr. 2006, 136:1940S-1946S.
10. German A.J., Hervera M., Hunter L., Holden S.L., Morris P.J., Biourge V., Trayhurn P. Improvement in insulin resistance and reduction in plasma inflammatory adipokines after weight loss in obese dogs. Domest. Anim. Endocrinol. 2009, 37:214-226.
11. German A.J., Ryan V.H., German A.C., Wood I.S., Trayhurn P. Obesity, its associated disorders and the role of inflammatory adipokines in companion animals. Vet. J. 2010, 185:4-9.
12. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
13. Ishioka K., Hosoya K., Kitagawa H., Shibata H., Honjoh T., Kimura K., Saito M. Plasma leptin concentration in dogs: effects of body condition score, age, gender and breeds. Res. Vet. Sci. 2007, 82:11-15.
14. Jeusette I.C., Detilleux J., Shibata H., Saito M., Honjoh T., Delobel A., Istasse L., Diez M. Effects of chronic obesity and weight loss on plasma ghrelin and leptin concentrations in dogs. Res. Vet. Sci. 2005, 79:169-175.
15. Kealy R.D., Lawler D.F., Ballam J.M., Mantz S.L., Biery D.N., Greeley E.H., Lust G., Segre M., Smith G.K., Stowe H.D. Effects of diet restriction on life span and age-related changes in dogs. J. Am. Vet. Med. Assoc. 2002, 220:1315-1320.
16. Kjelgaard-Hansen M., Goggs R., Wiinberg B., Chan D.L. Use of serum concentrations of interleukin-18 and monocyte chemoattractant protein-1 as prognostic indicators in primary immune-mediated hemolytic anemia in dogs. J. Vet. Intern. Med. 2011, 25:76-82.
17. Kopelman P.G. Obesity as a medical problem. Nature 2000, 404:635-643.
18. Laflamme D.P. Development and validation of a body condition score system for dogs. Canine Pract. 1997, 22:10-15.
19. Larson B.T., Lawler D.F., Spitznagel E.L., Kealy R.D. Improved glucose tolerance with lifetime diet restriction favorably affects disease and survival in dogs. J. Nutr. 2003, 133:2887-2892.
20. Levin M., Romano T., Matassa K., De G.S. Validation of a commercial canine assay kit to measure pinniped cytokines. Vet. Immunol. Immunopathol. 2014, 160:90-96.
21. McInnes I.B. Cytokines. Kelley's Textbook of Rheumatology 2008, 367-377. Saunders, Philadelphia.
22. O'Neill S., Drobatz K., Satyaraj E., Hess R. Evaluation of cytokines and hormones in dogs before and after treatment of diabetic ketoacidosis and in uncomplicated diabetes mellitus. Vet. Immunol. Immunopathol. 2012, 148:276-283.
23. Odegaard J.I., Chawla A. Alternative macrophage activation and metabolism. Annu. Rev. Pathol. 2011, 6:275-297.
24. Samaan M.C. The macrophage at the intersection of immunity and metabolism in obesity. Diabetol. Metab. Syndr. 2011, 3:29.
25. Sassi F., Devaux M. Obesity Update 2012 2012, Published online by the OECD (The Organisation for Economic Co-operation and Development) based in Paris. Available at: http://www.oecd.org/dataoecd/1/61/49716427.pdf. (Last accessed on 2 January 2015).
26. Satyaraj E. Emerging paradigms in immunonutrition. Top. Companion Anim. Med. 2011, 26:25-32.
27. Shoelson S.E., Lee J., Goldfine A.B. Inflammation and insulin resistance. J. Clin. Invest. 2006, 116:1793-1801.
28. Tvarijonaviciute A., Ceron J.J., Holden S.L., Cuthbertson D.J., Biourge V., Morris P.J., German A.J. Obesity-related metabolic dysfunction in dogs: a comparison with human metabolic syndrome. BMC Vet. Res. 2012, 8:147.
29. Tvarijonaviciute A., Tecles F., Martinez-Subiela S., Ceron J.J. Effect of weight loss on inflammatory biomarkers in obese dogs. Vet. J. 2012, 193:570-572.
30. Van de Velde H., Janssens G.P., Rochus K., Duchateau L., Scharek-Tedin L., Zentek J., Nguyen P., Cox E., Buyse J., Biourge V., Hesta M. Proliferation capacity of T-lymphocytes is affected transiently after a long-term weight gain in Beagle dogs. Vet. Immunol. Immunopathol. 2013, 152:237-244.
31. Van de Velde H., Janssens G.P., Stuyven E., Cox E., Buyse J., Hesta M. Short-term increase of body weight triggers immunological variables in dogs. Vet. Immunol. Immunopathol. 2012, 145:431-437.
32. Wellen K.E., Hotamisligil G.S. Inflammation, stress, and diabetes. J. Clin. Invest. 2005, 115:1111-1119.
33. Yazwinski M., Milizio J.G., Wakshlag J.J. Assessment of serum myokines and markers of inflammation associated with exercise in endurance racing sled dogs. J. Vet. Intern. Med. 2013, 27:371-376.
34. Zoran D.L. Obesity in dogs and cats: a metabolic and endocrine disorder. Vet. Clin. N. Am. Small Anim. Pract. 2010, 40:221-239.